http://www.fpnotebook.com/
Hepatitis B Postexposure Prophylaxis in Newborns
Aka: Hepatitis B Postexposure Prophylaxis in Newborns, Hepatitis B Prophylaxis in Newborns, Postexposure Prophylaxis for Hepatitis B in Newborns, Perinatal Hepatitis B Exposure, Infants born to Mothers with Hepatitis B, HBV Vertical Transmission
See AlsoPostexposure Prophylaxis for Hepatitis B Hepatitis B
EpidemiologyU.S. Mothers with Chronic Hepatitis B : 19,000 per year U.S. Prevalence : 4.9%
PathophysiologyVertical transmission is uncommon prior to delivery (represents only 5% of cases)Risk of in utero transmission increases if high viral load and HebBeAg positive Vertical transmission risk to newborn from HBsAg positive motherHBeAg Negative: 10% vertical transmission riskHBeAg Positive: 70-90% vertical transmission risk Outcomes from perinatal Hepatitis B infectionOne quarter with die in adulthood from Cirrhosis or liver cancer
EfficacyProphylaxis prevents 90% of perinatal Hepatitis B infections if given within 12 hours of birth
Protocol: Administer HBIG and HepB <12 hours from birthScreening for Hepatitis B IndicationsAll women in pregnancy (as part of Prenatal Lab s) Women presenting to labor and delivery with unknown Hepatitis B status Management for positive casesRefer to gastroenterology or infectious disease specialist Consider for antiviral agents (category B agents include Telbivudine and Tenofovir ) under specialist direction Hospitalize patients with signs or symptoms of hepatic failure Indications for prophylaxisMaternal Hepatitis B positive Maternal Hepatitis B status unknown or positive Hepatitis B Immunoglobulin (HBIG)HBIG 0.5 ml within 12 hours of birth Hepatitis B Vaccine (HepB)Initial dose within 12 hours of birthAdminister at separate site from HBIG Repeat Heptavax at exactly 1 and 6 months of age Factors that do not impact transmissionCeserean section does not reduce transmission Breast Feeding does not increase transmission rate
MonitoringCheck follow-up Hepatitis B labs at age 9-15 monthsHepatitis B Surface Antigen (HBsAg )Hepatitis B Surface Antibody (HBsAb)If Antibody titer <10 mIU/ml, revaccinate with a repeat of entire Hepatitis B series Retest HBsAb after second series
Prevention: Adult transmissionSee Hepatitis B Test all household contacts, sexual contacts, or IVDA contacts Hepatitis B Vaccine
ReferencesEuler (2003) Pediatr Infect Dis J 22:123-9 Vu Lam (2010) Am Fam Physician 82(10): 1225-9 (2007) Obstet Gynecol 110(4): 941-56